معرفی
Professor Arjen Dondorp serves as Deputy Director and Head of the Malaria and Critical Illness Department at the Mahidol-Oxford Tropical Medicine Research Unit (MORU) in Bangkok, Thailand. He holds a Professorship in Tropical Medicine at the University of Oxford and a visiting Professorship at Mahidol University. His career since 2001 has centered on combating severe malaria and antimalarial drug resistance across Southeast Asia and Africa, with significant contributions to global treatment guidelines.
Trained in the Netherlands as an intensive care and infectious diseases physician, Professor Dondorp's expertise bridges clinical medicine and tropical disease research. His foundational work established artesunate as the global standard for severe malaria treatment after demonstrating 35% mortality reduction in adults compared to quinine.
His research program focuses on malaria pathophysiology, artemisinin resistance mechanisms, and critical care optimization in resource-limited settings. Current priorities include genomic surveillance of drug-resistant parasites in the Greater Mekong Subregion, development of triple-combination antimalarials, and implementation of rapid diagnostic tools for febrile illnesses in rural communities. His work integrates laboratory science with field epidemiology to address translational challenges in tropical medicine.
Recent publications reveal expanding research horizons beyond malaria into critical care phenotyping (ARDS subphenotyping) and pandemic preparedness (COPCOV trial). The predominant themes across 2024-2025 outputs involve malaria genomics, operational research for elimination programs, and pharmacological innovations against drug-resistant parasites, with significant contributions to WHO policy frameworks.
No major scientific awards are explicitly documented in the source materials, though his leadership roles indicate high professional recognition.
Professor Dondorp chairs the Global Fund's Regional Artemisinin-resistance Initiative steering committee, directing a major regional grant for malaria elimination across the Greater Mekong Subregion. His grant portfolio emphasizes operational research translating laboratory findings into field applications, particularly for village-level malaria workers. While specific students aren't listed, his departmental leadership and Oxford professorship imply ongoing mentorship of junior researchers in tropical medicine.
The Malaria and Critical Illness Department at MORU operates as a hub for translational research, combining clinical studies in Thai hospitals with molecular surveillance across Southeast Asia. The team maintains extensive collaborations with institutions in Africa, Australia, Europe, and South Asia, focusing on capacity building for malaria elimination and critical care improvement in tropical regions.
